Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Antitussives, Anticholinergics and Honey in Acute Bronchitis
NCT03738917Phase 4Completed
- Sponsor
- IDIAPJGol
- Start
- Feb 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dextromethorphan, ipratropium bromide and Revamil in acute bronchitis (4 arms), sponsored by IDIAPJGol. Primary endpoint: Duration of moderate-severe cough at 29 days. Started Feb 2019; status: completed.
02
Drugs
dextromethorphanipratropium bromideRevamil
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT03738917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738917.